Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
Portfolio Pulse from Lara Goldstein
Optimi Health (OTCQX:OPTHF) has received approval from Health Canada to supply MDMA and psilocybin drugs to the country's Special Access Program (SAP). The company has also secured CA$1M in private financing through a non-dilutive debt financing agreement. The loan, bearing a 7.5% annual interest rate, is secured against the company's assets and will be fully repaid by August 29, 2026.
September 08, 2023 | 3:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Optimi Health's approval to supply psychedelics to Canada's SAP and the secured CA$1M in private financing could potentially boost the company's revenue and market position.
The approval from Health Canada allows Optimi Health to supply MDMA and psilocybin drugs to the SAP, potentially increasing its revenue. Additionally, the secured CA$1M in private financing provides the company with additional capital for its operations, which could enhance its market position.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100